| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026265A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | WO1997026264A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | WO1997026000A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | WO1997025984A1 Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors |
| 07/24/1997 | WO1997025961A1 Bowman-birk inhibitor for male sexual dysfunction |
| 07/24/1997 | CA2243531A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |
| 07/24/1997 | CA2241567A1 Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use |
| 07/24/1997 | CA2241565A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
| 07/23/1997 | EP0785272A1 Prolyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785271A1 Threonyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785269A1 Histidyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785267A1 Valyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785266A1 Arginyl-tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785265A1 Aspartyl tRNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785264A1 Lencyl t-RNA synthetase of Staphylococcus aureus |
| 07/23/1997 | EP0785263A1 Tryptophanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785262A1 Phenylalanyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785261A1 Glutamyl-tRNA synthetase from Staphylococcus aureus |
| 07/23/1997 | EP0785258A1 Staphylococcus aureus tyrosyl-tRNA synthetase |
| 07/23/1997 | EP0784980A1 Collagen hydrolysis accelerator |
| 07/23/1997 | EP0784672A1 Human inositol monophosphatase h1 |
| 07/23/1997 | EP0540717B1 UNSATURATED 17$g(b)-SUBSTITUTED 3-CARBOXY STEROIDS |
| 07/22/1997 | US5650414 Pyrazolopyridines or imidazolopyridines |
| 07/22/1997 | US5650394 Use of urinastatin-like compounds to prevent premature delivery |
| 07/17/1997 | WO1997025428A1 Apo-2 ligand |
| 07/17/1997 | WO1997025425A1 Wsx receptor and ligands |
| 07/17/1997 | WO1997025322A1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 07/17/1997 | WO1997025046A1 Novel substituted imidazole compounds |
| 07/17/1997 | WO1997025042A1 Use of an agonist of ppar-alpha and ppar-gamma for the treatment of syndrom x |
| 07/17/1997 | WO1997024929A1 Human g-protein coupled receptor |
| 07/17/1997 | CA2666263A1 Apo-2 ligand |
| 07/17/1997 | CA2242632A1 Use of an antagonist of ppar-alpha and ppar-gamma for the treatment of syndrome x |
| 07/17/1997 | CA2241564A1 Wsx receptor and ligands |
| 07/16/1997 | EP0783508A1 The oligosaccharide structure of a ligand for e and p selectin |
| 07/16/1997 | EP0672056B1 Calcium channel blocking polypeptides from filistata hibernalis |
| 07/16/1997 | EP0580624B1 Novel cytarabine derivatives, their production and use |
| 07/16/1997 | CN1154699A (Azetidin-1-ylalkyl) lactams as tachykinin antagonists |
| 07/15/1997 | US5648492 Process for preparing isoquinoline compounds |
| 07/15/1997 | US5648478 Tissue-specific enhancer active in prostate |
| 07/15/1997 | US5648386 Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof in pharmaceutical compositions and animal feeds |
| 07/10/1997 | WO1997024334A1 Benzimidazole derivatives |
| 07/09/1997 | EP0783002A2 Dual action inhibitors |
| 07/09/1997 | EP0782630A1 Polycystic kidney disease gene |
| 07/09/1997 | CN1154067A Use of a progesterone antagonist and of a gestagen for the treatment of endometriosis or leiomyomata uteri |
| 07/09/1997 | CN1153658A Medicine for nephropathy and gastropathy |
| 07/08/1997 | US5646308 Benzopyran derivatives |
| 07/08/1997 | US5646143 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 07/08/1997 | US5645830 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 07/03/1997 | WO1997023507A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/03/1997 | WO1997023464A1 Phenylimidazolidines and use thereof as an antiandrogenic agent |
| 07/03/1997 | WO1997023462A1 Quinoline and quinazoline compounds useful in therapy |
| 07/03/1997 | WO1997023461A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997023460A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors |
| 07/03/1997 | WO1997016185A3 A pharmaceutical composition for the treatment of autoimmune diseases |
| 07/03/1997 | CA2237543A1 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 07/02/1997 | EP0781340A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 07/02/1997 | EP0781280A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors |
| 07/02/1997 | EP0781268A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system |
| 07/02/1997 | EP0781126A2 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system |
| 07/02/1997 | CN1153473A Use of droloxifene for treatment of cardiovascular diseases |
| 07/01/1997 | US5644055 Cyclization of indole or quinoline compound, enzyme inhibitors, treatment of cardiovasacular disorders |
| 07/01/1997 | US5643932 Superoxide radical inhibitor |
| 07/01/1997 | US5643930 6-heterocyclic-4-amino-1,3,4,5,-tetrahydrobenz [cd]indoles |
| 07/01/1997 | US5643896 2-Benzyl-3-arylbenzothiophenes |
| 07/01/1997 | CA2128248C Amino acids useful as inhibitors of the advanced glycosylation of proteins |
| 06/26/1997 | WO1997022619A2 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022618A1 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME |
| 06/26/1997 | WO1997022341A1 Endothelin receptor antagonists |
| 06/26/1997 | WO1997022334A1 Pge-1 containing lyophilized liposomes for use in the treatment of erectile dysfunction |
| 06/26/1997 | CA2240489A1 Inhibitors of interleukin-1.beta. converting enzyme |
| 06/25/1997 | EP0780397A2 New 17alpha-Cyanomethylestra-4,9-dien-derivatives, a process for the production of these compounds and pharmaceutical compositions containing them |
| 06/25/1997 | EP0780128A2 Crotonic acid amide derivatives and lipoprotein containing compositions |
| 06/25/1997 | EP0779889A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE |
| 06/25/1997 | EP0779817A1 Enteral vaccine for vaginal infections |
| 06/25/1997 | EP0706376B1 Anti-angiogenic compositions and methods of use |
| 06/25/1997 | CN1152868A Use of droloxidfene for the treatment of cardiovascular diseases |
| 06/24/1997 | US5641875 Dna construct encoding immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cell comprising same |
| 06/24/1997 | US5641863 Immunoglobulin g fc receptor comprising extracellular, transmembrane and cytoplasmic domains or functional portions thereof, which renders phagocytic cells comprising same |
| 06/24/1997 | US5641797 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd] indoles |
| 06/24/1997 | US5641792 Benzoylguanidines substituted by heterocyclic N-oxide, process for their preparation and pharmaceutical compositions containing them |
| 06/24/1997 | US5641779 Selective ligands of 5-HT1D -5-HT1B receptors derived from indolepiperazine which are useful medicaments |
| 06/24/1997 | US5641777 Neurokinin receptor antagonist |
| 06/24/1997 | US5641752 Methods of using endothelin antagonists |
| 06/22/1997 | CA2193610A1 17 .alpha.-cyanomethylestra-4, 9-dien derivative compounds, processes for making same and pharmaceutical compositions containing same |
| 06/19/1997 | WO1997021707A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021704A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021703A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | WO1997021439A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness |
| 06/19/1997 | WO1997021435A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240115A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240111A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240108A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2240048A1 Antagonists of gonadotropin releasing hormone |
| 06/19/1997 | CA2211161A1 Medicament intended to the treatment of obsessive compulsive troubles, sleep apnoea, sexual dysfunctions, emesa and transport sickness |